التفاصيل البيبلوغرافية
| العنوان: |
Semen quality and testicular adrenal rest tumour development in 46, XY congenital adrenal hyperplasia: the importance of optimal hormonal replacement. |
| المؤلفون: |
Rohayem, Julia, Bäumer, Lena Maria, Zitzmann, Michael, Fricke-Otto, Susanne, Mohnike, Klaus, Gohlke, Bettina, Reschke, Felix, Jourdan, Claus, Müller, Herman L., Dunstheimer, Désirée, Weigel, Johannes, Jorch, Norbert, Müller-Rossberg, Elke, Lankes, Erwin, Gätjen, Imke, Richter-Unruh, Annette, Hauffa, Berthold P., Kliesch, Sabine, Krumbholz, Aniko, Brämswig, Jürgen |
| المصدر: |
European Journal of Endocrinology; Apr2021, Vol. 184 Issue 4, p487-501, 15p |
| مصطلحات موضوعية: |
ADRENOGENITAL syndrome, SEMEN analysis, HAIR analysis, ULTRASONIC imaging, MALE infertility |
| مستخلص: |
Objective: To study the impact of the quality of therapeutic control on f ertility and on the prevalence of testicular adrenal rest tumours (TART) in young males with congenital adre nal hyperplasia (CAH). Design: Combined cross-sectional and retrospective clinical study. Methods: Twenty-nine patients and age-matched controls underwent clinical investigation, including semen analysis, testicular and adrenal ultrasound imaging, and serum and hair steroid analysis. The quality of therapeutic control was categorized as 'poor', 'moderate' or 'medium'. Evaluation of current control was based on concentrations of 17-hydroxy-progesterone and androstenedione in serum and 3 cm hair; previous control was categorized based on serum 17-hydroxy-progesterone concentrations during childhood and puberty, anthropometric and puberty data, bone age data and adrenal sizes. Results: Semen quality was similar in males with CAH and controls (P = 0.066), however patients with 'poor' past control and large TART, or with 'poor' current CAH control had low sperm counts. Follicle-stimulating hormone was decreased, if current CAH control was 'poor' (1.8 ± 0.9 U/L; 'good': 3.9 ± 2.2 U/L); P = 0.015); luteinizing hormone was decreased if it was 'poor' (1.8 ± 0.9 U/L; P = 0.041) or 'moderate' (1.9 ± 0.6 U/L; 'good': 3.0 ± 1.3 U/L; P = 0.025). None of the males with 'good' past CAH control, 50% of those with 'moderate' past control and 80% with 'poor past control had bilateral TART. The prevalence of TART in males with severe (class null or A) CYP21A2 mutations was 53% and 25% and 0% in those with milder class B and C mutations, respectively. Conclusions: TART development is favoured by inadequate long-term hormonal control in CAH. Reduced semen quality may be associated with large TART. Gonadotropin suppression by adrenal androgen excess during the latest spermatogenic cycle may contribute to impairment of spermatogenesis. [ABSTRACT FROM AUTHOR] |
|
Copyright of European Journal of Endocrinology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder